(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ENBOMAY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ENBOMAY

ST13

US500000099123433

Class

5

Filing

99123433

Registration

7985705

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

06/16/2026

Trademark type

Word

Nice classes

5

Filing date

04/07/2025

Registration date

10/14/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/14/2025

Last transaction

06/16/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

26

Owner location

HAARLEM, NL

Examiner

WOMEODU, ROBIN W

Current location

Historical data usage

Holders and representatives

Holders

Merck Sharp & Dohme B.V.

Representatives

Lisa M. Dellamura Merck & Co., Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment and prevention of bonecardiovascularcentral nervous systemdermatologicalendocrinehematologicalhepatologicalimmunologicalgastrointestinalgenitourinarygynecologicalmetabolicmusculoskeletalnephrologicalneurologicaloncologicalophthalmicpsychiatricpulmonaryrenalrespiratoryurological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseasesasthmacancer and tumorschronic coughdiabeteshypertensioninsomniaintestinal infectionsskin disordersurinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Publications

History of USPTO decisions and trademark events.

20 publications found

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

06/16/2026

A7OK

AMENDMENT UNDER SECTION 7 - PROCESSED

05/28/2026

WDRL

OTQR WITHDRAWAL FROM PUBLICATION

05/18/2026

XXXX

POST REGISTRATION ACTION CORRECTION

03/24/2026

PRAN

POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED

03/24/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/23/2026

ES7R

TEAS SECTION 7 REQUEST RECEIVED

12/11/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/14/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/14/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/26/2025

PUBO

PUBLISHED FOR OPPOSITION

08/26/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/20/2025

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

08/01/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/16/2025

DOCK

ASSIGNED TO EXAMINER

07/14/2025

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

06/25/2025

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

06/25/2025

MAFR

APPLICATION FILING RECEIPT MAILED

04/07/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/07/2025

NWAP

NEW APPLICATION ENTERED

04/07/2025

Continuous trademark protection

Get notified about every new filing that threatens ENBOMAY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.